9:00 am Chair’s Opening Remarks

9:10 am FDA’s Efforts to Facilitate the Development of the Next Generation of CAR-T Cells

9:30 am Learnings from Kymriah®, The First Global CAR-T to Market

9:50 am Addressing the Challenges of Acquiring Cell Therapy Starting Material

10:20 am Live Q&A with Your Expert Speakers

10:35 am Virtual Speed Networking

MANUFACTURING TRACK

Facility Design to Enable Scale Up & Flexibility in Demand

11:30 am Key Considerations for the Launch & Scale-Up of Multiproduct/ Multiplatform Cell Therapy Manufacturing Facilities

  • John Tomtishen Director, Manufacturing, Chemistry Controls & Technical Operations, Legend Biotech

11:50 am The Role of Early Process Development & Facility Design in Assuring Commercial Success

12:10 pm Applying Henry Ford’s Manufacturing Revolution to Cell Therapy – The Cocoon Platform

  • Matthew Hewitt Head of Clinical Development, Personalized Medicine, Lonza

12:30 pm Live Q&A with Your Expert Speakers

  • John Tomtishen Director, Manufacturing, Chemistry Controls & Technical Operations, Legend Biotech
  • Knut Niss CTO, Mustang Bio
  • Matthew Hewitt Head of Clinical Development, Personalized Medicine, Lonza

Tech slam

12:45 pm Data-Driven Solutions to Understand and Minimize Failures of Cell Collections

  • Augustus Kilgore Sr. Global Training Consultant, Cell & Gene Therapy, Terumo Blood and Cell Technologies

12:55 pm Our Commitment To Providing Excellence To CAR T Cell Therapeutics

  • Teng Peng Technical Application Manager, ACROBiosystems

1:05 pm Innovate and Accelerate Cell Therapy Product Development Partnering with GenScript ProBio

  • Kenneth Lee Head of Commercial Division, Americas, GenScript ProBio

1:15 pm Refreshment Break

Synopsis

Take this break to follow up with our expert partners and explore the demo area!

Scaling-Up for Late Stage Trials & Commercial Capacity

1:45 pm Scaling Up TCR Manufacture

  • John Lunger Chief Patient Supply Officer, Adaptimmune

2:05 pm Manufacturing Platforms for Endogenous, Engineered, Autologous or Allogeneic TCR-T based Adoptive Cell Therapies

2:25 pm Technology Transfer & Scale-up Considerations for Allogeneic Antigen-Specific T-Cell Immunotherapies

2:45 pm Developing a Next Generation Non-Viral Cell Engineering Platform

3:05 pm Live Q&A with Your Expert Speakers

3:25 pm Coffee Networking Chats

Disruptive Innovation in Cell Therapy Analytics

4:25 pm The Quest Towards Accelerated Release Timelines for Autologous Cell Therapy Products

  • Therese Choquette Associate Director, Analytical Scientific Integrator, Janssen Inc.

4:50 pm Improving Manufacturing Turnaround Times by Fast-track Analytics

CMC & Quality Control to Develop Robust, Reproducible Therapeutic Products

5:15 pm The Role of Cryopreservation in the Variability of Regenerative Medicine Products

5:40 pm Identifying & Improving Quality Attributes for A Robust Manufacturing Process

  • Steven Feldman Director, Manufacturing & Process Development, Stanford School of Medicine

6:05 pm Emily Whitehead Foundation Presentation

6:20 pm Chair’s Closing Remarks

6:25 pm Post-Conference Networking

Synopsis

Follow up with those you have met online during the conference or join the open networking room to discuss the day with your colleagues.